chr3-15644539-A-G

Variant names:

• chr3-15644539-A-G
• rs587783004
• NM_001370658.1:c.623A>G

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1 PM2 PM5 PP2 PP3_Moderate PP5

The NM_001370658.1(BTD):​c.623A>G​(p.Asp208Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D208Y) has been classified as Likely pathogenic.

• Frequency:
  • Genomes: not found (cov: 31)
  • Exomes 𝑓: 6.8e-7 (0 hom.)
• Consequence: BTD NM_001370658.1 missense
• Clinical Significance: Pathogenic no assertion criteria provided P:1
• Conservation: PhyloP100: 8.95
• Publications: 0 publications found

Genes affected

BTD (HGNC:1122): (biotinidase) The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013]

BTD Gene-Disease associations (from GenCC):

• biotinidase deficiency

  Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, ClinGen, Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
• Leigh syndrome

  Inheritance: AR Classification: MODERATE Submitted by: ClinGen

ACMG classification

Our verdict: Pathogenic. The variant received 10 ACMG points.

• PM1: In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_001370658.1
• PM2: Very rare variant in population databases, with high coverage
• PM5: Other missense variant is known to change same aminoacid residue: Variant chr3-15644538-G-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 25035.
• PP2: Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 88 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Gene score misZ: -0.52516 (below the threshold of 3.09). Trascript score misZ: 0.15371 (below the threshold of 3.09). GenCC associations: The gene is linked to Leigh syndrome, biotinidase deficiency.
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.918
• PP5: Variant 3-15644539-A-G is Pathogenic according to our data. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr3-15644539-A-G is described in CliVar as Pathogenic. Clinvar id is 156002.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
BTD	NM_001370658.1	c.623A>G	p.Asp208Gly	missense_variant	Exon 4 of 4	ENST00000643237.3	NP_001357587.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
BTD	ENST00000643237.3	c.623A>G	p.Asp208Gly	missense_variant	Exon 4 of 4		NM_001370658.1	ENSP00000495254.2

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome AF: 6.84e-7 AC: 1 AN: 1461890 Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1 AN XY: 727248

African (AFR) AF: 0.00 AC: 0 AN: 33480

American (AMR) AF: 0.00 AC: 0 AN: 44724

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 26136

East Asian (EAS) AF: 0.00 AC: 0 AN: 39700

South Asian (SAS) AF: 0.00 AC: 0 AN: 86258

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53420

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 5768

European-Non Finnish (NFE) AF: 8.99e-7 AC: 1 AN: 1112008

Other (OTH) AF: 0.00 AC: 0 AN: 60396

GnomAD4 genome Cov.: 31

Alfa AF: 0.00 Hom.: 0

Bravo AF: 0.00000378

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:1

Revision: no assertion criteria provided

Submissions by phenotype

Biotinidase deficiency Pathogenic:1

-

Molecular Genetics Diagnostic Laboratory, Detroit Medical Center University Laboratories

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Uncertain	0.46
BayesDel_addAF	Uncertain	0.15	D
BayesDel_noAF	Uncertain	-0.030
CADD	Uncertain	25
DANN	Uncertain	1.0
DEOGEN2	Uncertain	0.55	.;.;D;.;.;.;T;.
Eigen	Uncertain	0.53
Eigen_PC	Uncertain	0.43
FATHMM_MKL	Pathogenic	1.0	D
LIST_S2	Uncertain	0.89	.;D;D;.;.;D;T;D
M_CAP	Pathogenic	0.42	D
MetaRNN	Pathogenic	0.92	D;D;D;D;D;D;D;D
MetaSVM	Uncertain	0.54	D
MutationAssessor	Uncertain	2.1	.;.;M;.;.;.;.;.
PhyloP100		8.9
PrimateAI	Benign	0.38	T
PROVEAN	Uncertain	-4.3	.;D;.;N;.;D;D;D
REVEL	Pathogenic	0.88
Sift	Uncertain	0.0030	.;D;.;T;.;D;D;D
Sift4G	Uncertain	0.0040	.;D;.;.;.;D;D;D
Polyphen		1.0	.;.;D;.;.;.;.;.
Vest4		0.80, 0.84, 0.77
MutPred		0.66		.;.;Loss of stability (P = 0.0385);.;.;.;.;.;
MVP		0.97
MPC		0.47
ClinPred		0.99	D
GERP RS		5.5
Varity_R		0.90
gMVP		0.93
Mutation Taster		=21/79	disease causing (ClinVar)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs587783004; hg19: chr3-15686046;